DK168655B1 - Frysetørret parenteralt præparat indeholdende phenylquinolincarboxylsyrer - Google Patents

Frysetørret parenteralt præparat indeholdende phenylquinolincarboxylsyrer Download PDF

Info

Publication number
DK168655B1
DK168655B1 DK447887A DK447887A DK168655B1 DK 168655 B1 DK168655 B1 DK 168655B1 DK 447887 A DK447887 A DK 447887A DK 447887 A DK447887 A DK 447887A DK 168655 B1 DK168655 B1 DK 168655B1
Authority
DK
Denmark
Prior art keywords
freeze
salt
fluoro
reconstitution
acid
Prior art date
Application number
DK447887A
Other languages
Danish (da)
English (en)
Other versions
DK447887A (da
DK447887D0 (da
Inventor
Chien-Chin Wu
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of DK447887D0 publication Critical patent/DK447887D0/da
Publication of DK447887A publication Critical patent/DK447887A/da
Application granted granted Critical
Publication of DK168655B1 publication Critical patent/DK168655B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK447887A 1986-08-28 1987-08-27 Frysetørret parenteralt præparat indeholdende phenylquinolincarboxylsyrer DK168655B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90125486A 1986-08-28 1986-08-28
US90125486 1986-08-28
US6020387 1987-06-10
US07/060,203 US4889862A (en) 1986-08-28 1987-06-10 Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids

Publications (3)

Publication Number Publication Date
DK447887D0 DK447887D0 (da) 1987-08-27
DK447887A DK447887A (da) 1988-02-29
DK168655B1 true DK168655B1 (da) 1994-05-16

Family

ID=26739681

Family Applications (1)

Application Number Title Priority Date Filing Date
DK447887A DK168655B1 (da) 1986-08-28 1987-08-27 Frysetørret parenteralt præparat indeholdende phenylquinolincarboxylsyrer

Country Status (17)

Country Link
US (1) US4889862A (ja)
EP (1) EP0261426B1 (ja)
JP (1) JP2629005B2 (ja)
KR (1) KR950006218B1 (ja)
AU (1) AU602715B2 (ja)
CA (1) CA1312824C (ja)
DE (1) DE3782480T2 (ja)
DK (1) DK168655B1 (ja)
ES (1) ES2052530T3 (ja)
FI (1) FI90824C (ja)
GR (1) GR3006608T3 (ja)
HU (1) HU199289B (ja)
IE (1) IE60490B1 (ja)
IL (1) IL83662A (ja)
NO (1) NO873626L (ja)
NZ (1) NZ221574A (ja)
PT (1) PT85612B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
HU206975B (en) * 1991-03-14 1993-03-01 Reanal Finomvegyszergyar Process for producing granulation and veterinary composition comprising water-soluble flumequine complex
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
ES2221147T3 (es) * 1997-02-05 2004-12-16 Kirin Beer Kabushiki Kaisha Composiciones liofilizadas conteniendo glicoesfingolipidos.
TWI232102B (en) 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
US20060008529A1 (en) * 2004-07-12 2006-01-12 Meyerhoff Mark E Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
ATE485849T1 (de) * 2005-12-02 2010-11-15 Univ Michigan Polymerzusammensetzungen, überzüge und vorrichtungen und herstellungs- und anwendungsverfahren damit

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US468299A (en) * 1892-02-02 John atkinson
DE433646C (de) * 1923-09-15 1926-09-09 Chem Fab Vorm E Schering Verfahren zur Herstellung in Wasser leicht loeslicher Derivate von Carbonsaeuren derChinolin- und Pyridinreihe
US3681495A (en) * 1969-08-25 1972-08-01 American Home Prod Freeze dried echothiophate iodide compositions
JPS5071816A (ja) * 1973-11-02 1975-06-14
US4036954A (en) * 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
AT356278B (de) * 1976-07-12 1980-04-25 Hoffmann La Roche Verfahren zur herstellung von injektions- loesungen
JPS5976017A (ja) * 1983-01-20 1984-04-28 Yamanouchi Pharmaceut Co Ltd 安定なプロスタグランジンｅ類製剤の製法
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
DE3483704D1 (de) * 1983-07-22 1991-01-17 Du Pont Phenylchinolinsaeure und derivate als antitumormittel.
DE3329952A1 (de) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg Verfahren zur verringerung einer truebung in kontrollseren
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
DE3782480T2 (de) 1993-04-08
JP2629005B2 (ja) 1997-07-09
DE3782480D1 (de) 1992-12-10
DK447887A (da) 1988-02-29
EP0261426A1 (en) 1988-03-30
KR950006218B1 (ko) 1995-06-12
NZ221574A (en) 1989-11-28
DK447887D0 (da) 1987-08-27
NO873626D0 (no) 1987-08-27
FI90824B (fi) 1993-12-31
EP0261426B1 (en) 1992-11-04
FI873701A0 (fi) 1987-08-26
PT85612A (en) 1987-09-01
CA1312824C (en) 1993-01-19
HU199289B (en) 1990-02-28
NO873626L (no) 1988-02-29
IE872290L (en) 1988-02-28
IE60490B1 (en) 1994-07-27
GR3006608T3 (ja) 1993-06-30
KR880002507A (ko) 1988-05-09
PT85612B (pt) 1990-05-31
IL83662A0 (en) 1988-01-31
AU602715B2 (en) 1990-10-25
IL83662A (en) 1991-09-16
US4889862A (en) 1989-12-26
HUT45398A (en) 1988-07-28
FI90824C (fi) 1994-04-11
AU7762287A (en) 1988-03-03
FI873701A (fi) 1988-02-29
JPS63115816A (ja) 1988-05-20
ES2052530T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
US4158707A (en) Parenteral preparations
US20080306137A1 (en) Pharmaceutical compositions comprising docetaxel and methods for preparation thereof
JP2022547558A (ja) 抗ウイルスプロドラッグ及びその医薬組成物
EP0215596B1 (en) Composition for injection of active type vitamins d3
DK168655B1 (da) Frysetørret parenteralt præparat indeholdende phenylquinolincarboxylsyrer
KR20030023875A (ko) 투명 수용성 마취제 조성물
US4866044A (en) Solubilized composition of poorly-soluble pharmaceutical product
US4866088A (en) Preparation process for an aqueous pharmaceutical solution of an active principle constituted by an organic acid
AU2011304917A1 (en) 5alpha-androstane (alkyl)-3beta,5,6beta-triol injection and preparation method therefor
CA1249223A (en) Solid drug formulations and stable suspensions
CA2564180A1 (en) Pharmaceutical preparation containing bacterial cell wall skeleton component
US5955456A (en) Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
JPH0692853A (ja) 注射剤および注射剤キット
DK159376B (da) Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid
KR20030016426A (ko) Ｎ-[ｏ-(ｐ-피발로일옥시벤젠술포닐아미노)벤조일]글리신·모노나트륨염·4수화물의 동결 건조 제제 및 그 제조 방법
EP2668952B1 (en) Aqueous formulations of bisphosphonates, vitamin D and benzyl alcohol suitable for subcutaneous or intramuscular use
KR102011714B1 (ko) 리세드론산 또는 그의 염 및 비타민d를 함유하는 경구용 에멀젼 조성물 및 그 제조방법
JP2020533318A (ja) ドセタキセル結合体の医薬組成物及び調製方法
RU2313346C2 (ru) Фармацевтическая композиция
WO2000044369A1 (en) Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent
RU1837878C (ru) Способ получени противоопухолевого средства на основе производного хинолинкарбоновой кислоты
WO2022123510A1 (en) Methisoprinol compositions
EP4134083A1 (en) Pharmaceutical compositions of bortezomib
EP0338081A1 (en) Oily rectal instillation
DK146754B (da) Fremgangsmaade til fremstilling af vandige oploesninger af sterolglykosider eller esterderivater deraf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed